Categories AlphaGraphs, Earnings, Health Care

Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results

Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today.

Net sales declined 12% year-over-year to $10.1 billion.

Net earnings decreased 48% to $1 billion while EPS fell 47% to $0.59. Adjusted earnings were down 23% to $1.8 billion while adjusted EPS dropped 22% to $1.03.

Abbott expects adjusted EPS from continuing operations to be $4.30-4.50 for the full year of 2023.

Prior performance


Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Viewing Highlight